A top U.S. health official on Wednesday touted the therapeutic potential of psychedelics like psilocybin and MDMA, and he also slammed ongoing federal restrictions that are inhibiting research into marijuana. Francis Collins, director of the National Institutes of Health (NIH), was asked about psychedelics and cannabis by Sen. Brian Schatz (D-HI) during a Senate Appropriations … Continue reading Top Federal Health Official Touts Psychedelics’ Therapeutic Benefits And Slams Marijuana Scheduling